About the Company
Medpace Holdings, Inc. (alt. Medpace) is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio. The company started trading stock as a public firm in 2016.
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological Research
Employees
5385
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MEDP News
Medpace Holdings, Inc. Just Beat EPS By 30%: Here's What Analysts Think Will Happen Next
It's been a good week for Medpace Holdings, Inc. (NASDAQ:MEDP) shareholders, because the company has just released its latest ...
Medpace Holdings Inc (MEDP) Surpasses Analyst Revenue and Earnings Projections in Q1 2024
Medpace's operational efficiency is further underscored by its EBITDA of $115.7 million, marking a 24.6% increase from the ...
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2024 Earnings Call Transcript
Medpace Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the ...
Medpace Holdings, Inc. Reports First Quarter 2024 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, ...
Medpace: Q1 Earnings Snapshot
Medpace expects full-year earnings to be $10.79 to $11.47 per share, with revenue in the range of $2.15 billion to $2.2 billion. This story was generated by Automated Insights ...
Cleveland-area company had highest stock growth in Ohio last week
Stock prices for 11 major Ohio companies increased by at least 2% last week. This was led by Eaton Corp., which though headquartered in Ireland has a major corporate presence in Beachwood, which ...
Medpace raised to Buy at Jefferies after Q1 earnings beat
Medpace Holdings (MEDP) stock receives an upgrade from Jefferies as the contract research organization exceeds Q1 earnings expectations. Read more here.
Decoding 5 Analyst Evaluations For Medpace Hldgs
Analysts have recently evaluated Medpace Hldgs and provided 12-month price targets. The average target is $437.0, accompanied ...
MEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024
Stock Market News, Stock Advice & Trading Tips Medpace Hldgs (NASDAQ:MEDP) just reported results for the first quarter of ...
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and ...
Stocks Set to Open Higher as Investors Await Key U.S. Inflation Data and Big Tech Earnings
In other news, market participants and observers perceive higher-than-expected interest rates in the face of persistent inflation as the most significant threat to financial stability, the Fed said in ...
Apple Loses Market Share in China, GM Surges in Pre-Market Following Upward Revisions for 2024 Projections, and More News
Smartphone shipments from Apple in China fell 19% in the first quarter due to competition from Huawei. Its market share ...
Loading the latest forecasts...